Company Number: 13216605

Analysis Date: 2025-07-20 14:19 UTC

Financial Health Assessment for Mylestone Limited

---

1. Financial Health Score: D

Explanation:
Mylestone Limited is currently showing significant financial distress indicators. The company has negative net assets of £750 as at 29 February 2024, reflecting a net liability position. This is a critical symptom suggesting the company’s financial foundation is weak. Despite being a micro-entity with minimal filing requirements, the negative equity and net current liabilities suggest unhealthy financial “vital signs.” Therefore, the financial health is rated as "D," indicating substantial risk and need for immediate attention.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Fixed Assets	£6,300	Small asset base, slightly increased from zero.
Current Assets	£150	Extremely low liquid resources available.
Current Liabilities	£7,200	Significant short-term debts due within a year.
Net Current Assets (Working Capital)	(£7,050)	Negative working capital—a symptom of cash flow stress.
Net Assets (Shareholders Funds)	(£750)	Negative equity indicates liabilities exceed assets.
Share Capital	£100	Minimal equity invested by shareholders.
Employee Count	1	Very small operation, limited resource base.

Interpretation of Vital Signs:

• The company’s negative working capital is a critical symptom of distress. It indicates that Mylestone Limited does not have enough current assets (cash, receivables, stock) to cover its immediate liabilities, which could lead to liquidity problems.
• The negative net assets position means the company’s total liabilities exceed its total assets. This undermines the financial stability and may affect creditor confidence and ability to obtain finance.
• The small fixed asset base and limited capital suggest limited operational capacity and possibly constrained growth.
• The company remains classified as dormant, which implies minimal or no trading activity, raising questions about operational viability.

---

3. Diagnosis: Overall Financial Condition Assessment

Mylestone Limited’s financial “vital signs” reveal symptoms of early financial distress. Negative working capital and net liabilities are classic indicators of poor liquidity and solvency challenges. The company’s dormant status, despite having one employee and some assets, points to limited business activity or possibly a paused operational phase. The recent appointment of a new director in 2024 may indicate attempts to restructure or revive the business, but current financials show the company is operating with insufficient resources to meet its obligations.

The negative shareholders’ funds reflect an erosion of equity, which could be due to past losses or unrecouped expenses. This financial “symptom” could undermine stakeholder confidence and restrict the company’s ability to secure credit or investment. Given the small scale (micro-entity) and minimal capital, the company has little financial buffer to absorb shocks.

---

4. Prognosis: Future Financial Outlook

If the current trends continue without intervention, the company risks:

• Increasing liquidity problems, potentially leading to payment defaults.
• Difficulties in meeting statutory obligations or sustaining operations.
• Potential formal insolvency processes if liabilities continue to outweigh assets and cash flow remains negative.

However, the prognosis can improve if management takes decisive steps to:

• Inject fresh capital or reduce liabilities.
• Increase operational activity to generate revenue and positive cash flow.
• Restructure debt arrangements to improve working capital.

Without such actions, the company’s financial health will likely deteriorate further.

---

5. Recommendations: Specific Actions to Improve Financial Wellness

• Capital Injection: Consider increasing shareholder equity to improve net asset position and provide working capital for operations. This could be through new investment or shareholder loans.
• Liability Management: Negotiate with creditors to extend payment terms or reduce debts, alleviating short-term liquidity pressure.
• Operational Review: Evaluate business model and operational activities to identify revenue generation opportunities to transition from dormant status.
• Cash Flow Monitoring: Implement rigorous cash flow forecasting and management to ensure liquidity needs are met proactively.
• Financial Reporting: Enhance financial controls and reporting to detect early signs of distress and enable timely decision-making.
• Engage Professional Advice: Seek advice from financial and insolvency professionals to explore restructuring options before the situation worsens.

---

Medical Analogy Summary:
Mylestone Limited’s financial health shows clear symptoms of distress akin to a patient presenting with low blood pressure and dehydration — the company lacks the "healthy cash flow" and "financial reserves" necessary to sustain normal operations. Without intervention, these symptoms could progress to financial “organ failure” (insolvency). Immediate treatment through capital support and operational revival is critical to restore vitality.

---